21st CENTURY ONCOLOGY HOLDINGS,INC. (NYSEMKT:ICC) Files An 8-K Entry into a Material Definitive Agreement

21st CENTURY ONCOLOGY HOLDINGS,INC. (NYSEMKT:ICC) Files An 8-K Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement.

Story continues below

As previously disclosed, on December 6, 2016, 21st Century Oncology Holdings, Inc. (“we,” “our,” “us” or the “Company”), 21st Century Oncology, Inc. (“21C”), a subsidiary of the Company, and certain of the Company’s other subsidiaries entered into an Indenture Forbearance Agreement and Credit Agreement Forbearance Agreement (collectively, the “Forbearance Agreements”) with certain of 21C’s noteholders and lenders, respectively. The Forbearance Agreements required, among other things, that 21C enter into a transaction support agreement with its noteholders and lenders (as applicable) no later than December 15, 2016 (the “TSA Deadline”).

Effective as of December 15, 2016, we entered into amendments to the Forbearance Agreements (the “Amendments”) to, among other things, amend the TSA Deadline to January 4, 2017. The Amendments also require us to furnish certain operating and financial data and analysis to the parties to the Forbearance Agreements by the deadlines specified therein.


21st Century Oncology Holdings, Inc., formerly Radiation Therapy Services Holdings, Inc., is a physician-led provider of integrated cancer care (ICC) services. The Company’s operations are structured into two geographically organized groups: the U.S. Domestic, including approximately 145 radiation treatment centers, and International, including over 40 radiation treatment centers. It operates an integrated network of cancer treatment centers and affiliated physicians in the world which, as of December 31, 2015, deployed approximately 947 community-based physicians in the fields of radiation oncology, medical oncology, breast, gynecological, general surgery and urology. As of December 31, 2015, the Company’s physicians provided medical services at approximately 375 locations, including over 181 radiation therapy centers, of which 59 operated in partnership with health systems. Its cancer treatment centers in the United States are operated under the 21st Century Oncology brand.


21st CENTURY ONCOLOGY HOLDINGS, INC. (NYSEMKT:ICC) closed its last trading session at 0.0000 with shares trading hands.

An ad to help with our costs